NAD+ Therapy Cost in 2026: Annual Spend by Protocol (IV vs SubQ vs Oral)

In 2026, expected annual NAD+ spend is approximately: IV therapy $6,000–$25,000, in-clinic SubQ injections $1,800–$9,600, at-home SubQ telehealth $1,800–$5,400, sublingual wafers $480–$1,200, and oral NMN/NR $480–$1,200. For sustained NAD+ elevation, at-home SubQ delivers the lowest cost per percentage-point NAD+ increase in plasma — roughly one-twelfth the cost of clinic IV per unit of NAD+ delivered.

This guide is for buyers who already know they want to raise NAD+ and are now asking the hard question: how much will this actually cost over a full year, and where does the money go furthest? We rank the five real-world delivery routes by 2026 annual spend, then compare twelve named NAD+ providers head-to-head — including at-home telehealth, in-clinic injection chains (established clinic chains such as Options Medical Weight Loss post transparent NAD+ pricing too — $199/month for physician-administered injections across roughly 45 locations), and concierge IV services. Some at-home telehealth brands publish flat monthly NAD+ pricing upfront — for example, RxActivate lists NAD+ at $239/month with free shipping, while BreezeMeds is among the lowest, with NAD+ injections from $169/month (or a $210 nasal spray). If you want to skip the analysis, the ranked annual-cost table and the 12-provider price matrix are below.

Annual NAD+ cost at a glance — 5 protocols ranked

Ranked low-to-high by typical annual out-of-pocket spend. “Typical” excludes the long tail of concierge upcharges, B-vitamin add-ons, and ultra-high-dose protocols (those land in the high column).

Verified May 28, 2026 — Annual figures aggregate verified rates from 12 named providers (full matrix below). Excludes one-time consult fees ($0–$199), lab work ($0–$250), and shipping (typically $0–$25/order).

Quick facts: NAD+ pricing in 2026

Why NAD+ costs vary so much (the 1-minute version)

NAD+ price spreads of 10–50× between providers are not a pricing accident — they reflect five different cost stacks bundled together. Understanding which stack you’re actually paying for is the difference between a $600/year longevity plan and a $25,000/year concierge bill.

The five cost drivers, ranked by impact on your invoice:

1. Delivery method. IV requires sterile-room infrastructure, trained nursing staff, and 60–90 minutes of chair time per session. SubQ is a 30-second self-administered injection at home. That labor delta accounts for most of the $300–$800 IV price versus $20–$60 SubQ price.
2. Compounding pharmacy markup. NAD+ for injection is a compounded medication, made by a 503A or 503B pharmacy. Per-unit cost falls as batch size rises; large telehealth networks negotiate volume rates that solo clinics cannot.
3. Clinician oversight model. An in-person physician visit costs $150–$400 per touchpoint. A telehealth async consult costs $0–$50 amortized across the subscription. This is the biggest hidden price driver people miss.
4. Real estate and concierge premiums. Mobile in-home IV services and medspa locations in dense metros load $100–$400 onto each session for convenience and ambiance.
5. “NAD+ booster” upsells. Many IV clinics package NAD+ with glutathione, B-complex, magnesium, or vitamin C — easily doubling the bill. The base NAD+ is often listed at $300–$400; the loaded session can reach $1,200.

For a full mechanistic breakdown of why delivery route changes effective NAD+ delivered per dollar, see our full NAD+ bioavailability comparison.

Annual spend by protocol: the 2026 numbers

Here is what each route actually costs over a full year of consistent use, with the realistic frequency assumptions providers themselves publish in their FAQs.

IV NAD+ infusion — $6,000 to $25,000 typical

Per-session pricing ranges from $300 (low-end medspa with limited dosing, usually 250–500 mg) to $800 (concierge in-home with 1,000 mg). Most regular users land at one IV per week or one every two weeks. At $500/session weekly, that is $26,000/year. At $500/session every two weeks, that is $13,000/year. Monthly maintenance protocols at $500/session work out to $6,000/year.

The $6,000–$25,000 typical band reflects realistic adherence (people skip sessions when traveling) and the most common cadences IV clinics publish. The full theoretical range extends to $38,400/year for weekly $800 concierge IV — a real number some Peach IV and Drip Hydration clients pay.

In-clinic SubQ injection — $1,800 to $9,600 typical

Weekly injections at a wellness clinic typically run $100–$300 per shot. At $100/week you pay $5,200/year. At $300/week (Hone Health’s all-in lifestyle program with included clinician access lands here) you pay $15,600/year. Most buyers settle near $150–$185 per shot at chains like Florida Weight Loss MD and Vaccine Alliance, putting them in the $7,800–$9,600 zone.

The cost is higher than at-home SubQ for one reason: you are paying for the clinic visit, not the medication. The actual NAD+ vial costs roughly the same whether a nurse administers it or you inject it yourself.

At-home SubQ via telehealth — $1,800 to $5,400 typical

This is the value tier. Telehealth providers like BodyBuilding Health, CareBarRx, AgelessRx, and Strut Health package the async clinician visit, compounded NAD+ from a partner 503A pharmacy, sharps disposal kit, and shipping into a $99–$349/month subscription. At the $99–$199 entry tier you are paying $1,188–$2,388/year. Add baseline labs ($0–$200) and the all-in cost lands around $1,800–$2,600 for a fully managed year.

The $5,400 ceiling captures higher-dose protocols (300 mg, two doses per week) at premium telehealth tiers. Even at the high end, you are paying roughly half what an in-clinic SubQ program costs and one-fifth what concierge IV runs.

Sublingual NAD+ wafers — $480 to $1,200 typical

Compounded sublingual wafers or troches deliver 50–200 mg of NAD+ daily and price out at $3–$8 per dose depending on potency and compounding pharmacy. At $4/day that is $1,460/year; at modest dosing (every other day, or lower-strength) most buyers spend $480–$1,200/year.

Bioavailability is lower than SubQ (roughly 30–60% depending on the formulation), so the cost-per-percentage-point math is worse than at-home injection. But for needle-averse buyers who still want a prescription product with clinician oversight, this is the cheapest legitimate Rx route.

Oral NMN / NR supplements — $480 to $1,200 typical

NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are NAD+ precursors sold as consumer supplements without a prescription. Brand-name products like Tru Niagen, Elysium Basis, and Renue By Science run $40–$90/month at typical dosing. That is $480–$1,080/year. Generic NMN bulk powder is cheaper still — well under $365/year — but quality variance is real and third-party assays often show under-dosing.

The trade-off is mechanistic: precursors raise NAD+ indirectly through salvage-pathway conversion, and the magnitude of plasma elevation is smaller than direct NAD+ administration. For a deeper precursor analysis see our NMN vs NR comparison.

The cost-per-percentage-point NAD+ ratio (and why IV loses)

Annual spend numbers tell you what leaves your wallet. They do not tell you what enters your bloodstream. The honest way to compare NAD+ routes is cost per percentage-point increase in plasma NAD+ delivered. Here is the math published research and our full bioavailability comparison support.

Two findings stand out. First, at-home SubQ costs roughly one-twelfth what clinic IV costs per percentage-point of NAD+ delivered ($0.43 vs $5.00). The blood concentration gap closes quickly post-administration, but the wallet gap does not. Second, sublingual wafers are technically the cheapest per delivered percentage-point — but the absolute magnitude of NAD+ elevation is modest, so total physiological effect over a year is smaller than weekly SubQ.

12 NAD+ providers compared on price (May 2026)

All rates verified from provider websites May 27–28, 2026. Recommended value picks (highlighted green) are based on annual cost per percentage-point NAD+ delivered.

Verified May 28, 2026 — Annual estimates assume each provider’s published default cadence and entry-tier dosing. Higher-dose or higher-frequency protocols push toward the upper range.

At-home SubQ telehealth — the value tier

BodyBuilding Health, CareBarRx, AgelessRx, and Strut Health all sit in the $1,188–$4,188/year band. The product is materially identical across providers — compounded NAD+ from 503A or 503B partner pharmacies, weekly self-administered SubQ injection, async clinician oversight, monthly resupply. The differences are dosing flexibility, customer support quality, and bundled services like baseline labs.

BodyBuilding Health leads on raw price-to-value, with subscriptions starting at $99/month including consult and shipping. CareBarRx adds IV options for buyers who want flexibility between at-home maintenance and occasional in-person IV pulses. AgelessRx leans into the longevity-research brand, with messaging tied to clinical research and a slightly higher dosing ceiling. Compare top NAD+ providers side-by-side to pick the right fit.

In-clinic SubQ — convenience premium

Hone Health, Vaccine Alliance, Florida Weight Loss MD, and Restore Hyper Wellness anchor this tier. You are paying $4,200–$9,600/year for the same NAD+ molecule delivered the same way — but at a clinic, by a nurse or medical assistant, with in-person check-ins. For buyers who explicitly want the in-person model (anxiety about self-injection, wanting structured accountability, valuing relationship with a clinician) the premium is real and justified.

For everyone else, the math doesn’t favor in-clinic SubQ — at-home telehealth delivers the same dose for roughly 25–40% of the annual cost.

IV NAD+ — concierge premium

Drip Hydration, The IV Doc, Reset IV, Peach IV, and Restore (IV tier) are the headline brands in this segment. Annual spend ranges from $4,800 to $30,000 depending on cadence and dose. The case for IV is straightforward: peak plasma NAD+ during the infusion is higher than any other route, the experience can include in-home concierge service, and for acute use cases (jet lag, performance peaks before a known target date) the on-demand model fits.

The case against IV for chronic year-round NAD+ elevation is the cost-per-percentage-point ratio: you are paying roughly 12× what at-home SubQ costs for the same sustained NAD+ delivery profile. Read our full IV NAD+ therapy guide for the clinical context and IV vs injections vs oral comparison for the mechanistic head-to-head.

Hidden costs nobody mentions

Sticker pricing is what providers advertise. Real annual spend is what shows up on your statement after add-ons. Three categories of hidden cost consistently inflate the bill.

Consultation fees, lab work, shipping

Initial telehealth consults run $0–$199 depending on provider. Most subscription products bundle this in, but a la carte providers bill separately. Baseline labs are typically optional but recommended — $0–$250 if you go through an aggregator like Quest or LabCorp directly, or $50–$200 through the provider’s preferred lab partner. Shipping on monthly resupply is usually $0–$25 per order. Add it up: $50–$500 in first-year overhead beyond the sticker NAD+ price.

B-vitamin co-factor add-ons

Many clinics add B-complex, methylcobalamin, or folate to NAD+ injection protocols. The clinical rationale is real — B-vitamins are co-factors in NAD+ metabolism. The economic effect is also real: a $150 SubQ shot becomes a $200–$250 shot when bundled. Over a year of weekly injections, that is an extra $2,600–$5,200 in add-on revenue for the clinic.

At-home telehealth providers generally do not push co-factor add-ons because the model is subscription-flat rather than per-session-billable. This is a quiet structural cost advantage of the telehealth model.

“NAD+ booster” upsells at IV clinics

“Booster” cocktails — glutathione, vitamin C, magnesium, taurine, alpha-lipoic acid — are the highest-margin items on the IV clinic menu. They are routinely upsold at $50–$200 each on top of the NAD+ session. A buyer who agrees to two boosters per visit can double their effective annual IV spend without doubling the NAD+ dose. None of these add-ons changes the NAD+ pharmacokinetics in a clinically meaningful way for most buyers.

HSA, FSA, and insurance: what’s actually covered

Short version: insurance almost never covers NAD+ therapy in 2026. HSA/FSA partially covers some routes, with documentation.

• Commercial insurance (Aetna, BCBS, UnitedHealthcare, Cigna): NAD+ injections and IV are coded as wellness or elective and almost universally denied. Compounded medications are not on standard formularies. Do not budget for reimbursement.
• Medicare and Medicaid: Not covered. NAD+ has no FDA-approved indication that would trigger Part B or Part D coverage.
• HSA (Health Savings Account): Compounded SubQ or sublingual NAD+ with a valid prescription and a Letter of Medical Necessity (LMN) from a prescribing clinician is generally HSA-eligible. The LMN must tie the prescription to a documented medical condition. Telehealth providers like AgelessRx will issue LMNs on request.
• FSA (Flexible Spending Account): Same rules as HSA. LMN required for compounded products.
• IV NAD+ at medspas: Almost never HSA/FSA eligible. Medspa IV sessions are coded as cosmetic or wellness, which disqualifies them from tax-advantaged reimbursement under most plan rules.
• Oral NMN/NR supplements: Not HSA/FSA eligible. Consumer supplements without prescription requirements are excluded from tax-advantaged spending under IRS guidance.

The practical takeaway: if HSA/FSA matters to your budget math, lean toward compounded SubQ or sublingual NAD+ from a telehealth provider that can issue an LMN, and ask before subscribing.

3 cost scenarios: budget / mid-tier / premium

Worked examples using the verified provider rates above. Use these as a calculator-style benchmark for your own protocol.

Scenario A — Budget longevity buyer ($600/year)

• Daily oral NMN supplement (e.g. Tru Niagen or Elysium Basis): $40/month = $480/year
• Occasional sublingual NAD+ wafer (e.g. travel, recovery weeks): ~$120/year incremental
• No prescription, no labs, no telehealth subscription
• Total: ~$600/year

Best for: buyers who want a longevity stack baseline without committing to injections, who are skeptical of high-dose protocols, or who view NAD+ as a marginal lifestyle add-on rather than a core intervention.

Scenario B — Mid-tier serious buyer ($2,000/year)

• At-home SubQ NAD+ via BodyBuilding Health: $149/month entry-tier subscription = $1,788/year
• Baseline labs at signup: ~$150 one-time
• Optional: continue Tru Niagen as adjunct ($60/month) — skip in this base scenario
• Total: ~$2,000/year, all-in

Best for: buyers who treat NAD+ as a core longevity intervention, want a real prescription product, want predictable monthly spend, and prefer the convenience of at-home self-administration. This is the BMH editorial recommendation for most readers — and you can start with BodyBuilding Health here.

Scenario C — Premium concierge ($9,000–$15,000/year)

• Monthly in-home IV NAD+ at Peach IV or Drip Hydration: $650/session × 12 = $7,800/year
• Bi-weekly cadence (more aggressive): $650 × 26 = $16,900/year
• Add B-complex and glutathione boosters at $75 each per visit: $1,800–$3,900/year incremental
• Total: $9,000–$15,000/year, with extras pushing toward $20,000+

Best for: buyers who explicitly value concierge in-home service, want peak plasma NAD+ during infusion, and treat NAD+ as part of a broader high-touch performance protocol. Honest framing: the same NAD+ delivery profile can be sustained on at-home SubQ for ~20% of this cost, but the concierge experience itself is the product, not just the NAD+.

Which NAD+ protocol delivers the best value?

At-home SubQ via telehealth wins on every quantitative axis we tested:

• Lowest cost per percentage-point NAD+ delivered: $0.43 vs $5.00 for IV
• Lowest annual spend for a real Rx product: $1,188 entry tier
• Highest annual NAD+ exposure per dollar: weekly dosing for less than monthly IV cost
• Best HSA/FSA eligibility profile among injection routes
• No upsell cycle — flat subscription pricing protects against B-vitamin and booster add-ons

Oral NMN/NR wins on absolute price floor but loses on NAD+ elevation magnitude. Sublingual wafers win on cost-per-percentage-point (modest dose), but the absolute NAD+ exposure is smaller than weekly SubQ. IV wins on peak plasma during infusion and on concierge experience — and loses on every cost metric.

For the BMH editorial value pick, see the NAD+ + peptide longevity stack guide, which shows how at-home SubQ NAD+ pairs with peptides for buyers building a more complete protocol.

Where the cheapest option falls short (and when to upgrade)

Cheapest is not always best. Three honest scenarios where the value tier underperforms:

1. You want measurable acute peak NAD+ elevation for a specific event. Pre-event protocols (jet lag prep, recovery from a hard training block, focused performance peak before a defined target) genuinely benefit from IV pharmacokinetics. SubQ rises more slowly. For 1–4 sessions per year of acute use, the IV per-session cost is rational.

2. You will not self-inject, even with a sharps kit and clinical instructions. Roughly 15–20% of telehealth signups in this category cancel within 60 days specifically because they could not get comfortable with self-injection. If you already know this is you, in-clinic SubQ at Hone Health or a local wellness clinic is a more honest fit than buying a telehealth subscription you will abandon.

3. You want a single-relationship clinician model. If having one in-person physician who reviews labs, adjusts doses, and oversees your full longevity protocol matters to you, the all-in lifestyle programs at Hone Health and similar concierge clinics are the right purchase even though the math is worse.

For everyone else — and that is most BMH readers — at-home SubQ telehealth at $99–$199/month is the rational anchor. Upgrade selectively when use cases demand it.

Frequently Asked Questions

Sources

• BodyBuilding Health subscription pricing page (verified May 28, 2026)
• CareBarRx NAD+ pricing and IV options (verified May 28, 2026)
• AgelessRx NAD+ subscription tiers (verified May 28, 2026)
• Strut Health NAD+ injection product page (verified May 28, 2026)
• Hone Health NAD+ + lifestyle program pricing (verified May 27, 2026)
• Vaccine Alliance NAD+ clinic menu (verified May 27, 2026)
• Florida Weight Loss MD NAD+ shot pricing (verified May 27, 2026)
• Drip Hydration NAD+ IV menu (verified May 27, 2026)
• The IV Doc mobile NAD+ pricing (verified May 27, 2026)
• Reset IV NAD+ session pricing (verified May 27, 2026)
• Peach IV concierge NAD+ pricing (verified May 27, 2026)
• Restore Hyper Wellness IV + injection menu (verified May 27, 2026)
• IRS Publication 502 — HSA/FSA eligible medical expenses, 2025 edition
• BestMedsHub: NAD+ bioavailability by delivery method (2026)
• BestMedsHub: NMN vs NR precursor comparison
• BestMedsHub: IV vs injections vs oral NAD+ treatments

Related NAD+ guides

• NAD+ vs NMN vs NR — which NAD booster is right for you
• Does NAD+ actually work? — what the human studies really show
• NAD+ side effects & safety — risks, contraindications & safe dosing
• How to increase NAD+ naturally — food, fasting, exercise & sleep
• NAD+ IV therapy for addiction recovery — how it works, protocol & evidence